21 December 2023 INVION ACHIEVES MILESTONE FOR PHASE I/II HUMAN CLINICAL TRIAL IN NON-MELANOMA SKIN CANCERS 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post